Reference 2016-420

REF:            2016-420

Subject:        Multiparametric MRI usage data for your Trust




  1. Do you conduct multi-parametric MRI (mpMRI) scans (using T2-weighted, diffusion-weighted and dynamically enhanced sequences) before prostate biopsies?


If no, it would be helpful to know what the main reasons are:

If yes, it would be helpful if you can you provide an estimate of the percentage of men who receive an mpMRI scan before prostate biopsy:

  1. How many scanners do you have available to use for mpMRI scans before prostate biopsy?
  1. For each individual scanner used for mpMRI scans before prostate biopsy, please provide the following:
  • Make
  • Model
  • Magnetic field strength
  • Age
  • When the scanner is due to be replaced
  1. How many mpMRI scans before prostate biopsy do you estimate you carry out per year?
  • 0
  • Up to 50
  • 50 -100
  • 100 – 250
  • 250 – 500
  • 500 – 750
  • 750 – 1000
  • More than 1000

5.i. Do you intend to increase the number of mpMRI scans before prostate biopsy following the first results from the large clinical trial PROMIS?

The ASCO 2016 abstract has shown mpMRI as a triage test can identify one quarter of men (27%) who might safely avoid unnecessary biopsy, without impairing the detection of clinically significant cancer (

5.ii If yes, do you currently have sufficient resources and capacity to cope with this increase?

The information you provide may be re-used publicly. We look forward to hearing from you soon.




Please find information attached.

2016-420 Freedom of Information request – Multiparametric MRI usage data for your Trust [95 kb] PDF


Visitor restrictions

To protect you and our staff during the current outbreak of Covid-19 we’ve put in place significant restrictions on hospital visitors.

Full details of these can be found on our website.

We would like to thank you for your understanding and helping us stop the spread of Covid-19.

Read More

Stay Home. Protect the NHS. Save Lives.